BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1414495)

  • 1. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin.
    Worcester EM; Blumenthal SS; Beshensky AM; Lewand DL
    J Bone Miner Res; 1992 Sep; 7(9):1029-36. PubMed ID: 1414495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine.
    Ebisuno S; Nishihata M; Inagaki T; Umehara M; Kohjimoto Y
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S436-40. PubMed ID: 10541279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
    Priyadarshini ; Singh SK; Tandon C
    Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calprotectin-like protein is related to soluble organic matrix in calcium oxalate urinary stone.
    Umekawa T; Kurita T
    Biochem Mol Biol Int; 1994 Sep; 34(2):309-13. PubMed ID: 7849642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
    Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
    Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uropontin in urinary calcium stone formation.
    Hoyer JR
    Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
    Grover PK; Ryall RL
    Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts.
    Umekawa T; Iguchi M; Uemura H; Khan SR
    BJU Int; 2006 Sep; 98(3):656-60. PubMed ID: 16925768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.
    Shiraga H; Min W; VanDusen WJ; Clayman MD; Miner D; Terrell CH; Sherbotie JR; Foreman JW; Przysiecki C; Neilson EG
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):426-30. PubMed ID: 1729712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.
    Yamate T; Kohri K; Umekawa T; Iguchi M; Kurita T
    J Urol; 1998 Oct; 160(4):1506-12. PubMed ID: 9751404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal matrix protein is related to human prothrombin.
    Stapleton AM; Simpson RJ; Ryall RL
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1199-203. PubMed ID: 8216249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.
    Chutipongtanate S; Nakagawa Y; Sritippayawan S; Pittayamateekul J; Parichatikanond P; Westley BR; May FE; Malasit P; Thongboonkerd V
    J Clin Invest; 2005 Dec; 115(12):3613-22. PubMed ID: 16308573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.